Amelioration of fumonisin B1 hepatotoxicity in mice by depletion of T cells with anti-Thy-1.2

Toxicology

Volumn 223, Issue 3, 2006, Pages 191-201

  Sharma, Neelesh ^a   He, Quanren ^a   Sharma, Raghubir P ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Anti Thy 1.2; CD90.2 T cells; Fumonisin B1; Hepatotoxicity; Interferon ; Tumor necrosis factor

Indexed keywords

FUMONISIN B1; INTERLEUKIN 1ALPHA; LIVER ENZYME; MEMBRANE ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY; THY 1 ANTIGEN; THY 1.2 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ALLOANTIBODY; ANTI THY ANTIBODY; ANTI-THY ANTIBODY; CYTOKINE; FUMONISIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; LIVER TOXICITY; MALE; MOUSE; MOUSE STRAIN; NATURAL KILLER T CELL; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL DEPLETION; T LYMPHOCYTE; WILD TYPE; ANIMAL; DRUG EFFECT; IMMUNOLOGY; MACROPHAGE; TOXIC HEPATITIS;

ANIMALIA; EQUIDAE; GIBBERELLA MONILIFORMIS; MUS MUSCULUS; SUIDAE; ZEA MAYS;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CYTOKINES; FUMONISINS; HEPATITIS, TOXIC; ISOANTIBODIES; MACROPHAGES; MALE; MICE; MICE, NUDE; T-LYMPHOCYTES;

EID: 33744520750     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.03.021     Document Type: Article

References (39)

1. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 (1996) 787-793
2. Batey R.G., and Wang J. Molecular pathogenesis of T lymphocyte-induced liver injury in alcoholic hepatitis. Front. Biosci. 7 (2002) d1662-d1675
3. 1-induced localized activation of cytokine network in mouse liver. Food Chem. Toxicol. 40 (2002) 1483-1491
4. Blazka M.E., Wilmer J.L., Holladay S.D., Wilson R.E., and Luster M.I. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol. Appl. Pharmacol. 133 (1995) 43-52
5. 1 to B6C3F1 mice: a 14-day gavage study. Food Chem. Toxicol. 35 (1997) 981-989
6. Diaz G.J., and Boermans H.J. Fumonisin toxicosis in domestic animals: a review. Vet. Hum. Toxicol. 36 (1994) 548-555
7. Doherty D.G., Norris S., Madrigal-Estebas L., McEntee G., Traynor O., Hegarty J.E., and O'Farrelly C. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J. Immunol. 163 (1999) 2314-2321
8. Dutton M.F. Fumonisins, mycotoxins of increasing importance, their nature and their effects. Pharmacol. Therap. 70 (1996) 137-161
9. Enongene E.N., Sharma R.P., Bhandari N., Miller J.D., Meredith F.I., Voss K.A., and Riley R.T. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase. Toxicol. Sci. 67 (2002) 173-181
10. Galle P.R., Hofmann W.J., Walczak H., Schaller H., Otto G., Stremmel W., Krammer P.H., and Runkel L. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182 (1995) 1223-1230
11. Graeler M., and Goetzl E.J. Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells. FASEB J. 16 (2002) 1874-1878
12. 1 hepatotoxicity in mice is attenuated by depletion of Kupffer cells by gadolinium chloride. Toxicology 207 (2005) 137-147
13. 1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice. Environ. Health Perspect. 109 Suppl 2 (2001) 277-282
14. Ikehara S., Pahwa R.N., Fernandes G., Hansen C.T., and Good R.A. Functional T cells in athymic nude mice. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 886-888
15. 1. IARC Monograph on the Evaluation of carcinogenic Risks to Humans. IARC 822 (1992) 301-366
16. 1-induced apoptosis. Environ. Health Perspect. 109 Suppl 2 (2001) 315-320
17. Kondo T., Suda T., Fukuyama H., Adachi M., and Nagata S. Essential roles of the Fas ligand in the development of hepatitis. Nat. Med. 3 (1997) 409-413
18. 1. Mycopathologia 130 (1995) 163-170
19. Merrill Jr. A.H., Sullards M.C., Wang E., Voss K.A., and Riley R.T. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environ. Health Perspect. 109 Suppl 2 (2001) 283-289
20. Opitz H.G., Opitz U., Hewlett G., and Schlumberger H.D. A new model for investigations of T-cell functions in mice: differential immunosuppressive effects of two monoclonal anti-Thy-1, 2 antibodies. Immunobiology 160 (1982) 438-453
21. Payne S.G., Milstien S., Barbour S.E., and Spiegel S. Modulation of adaptive immune responses by sphingosine-1-phosphate. Semin. Cell Dev. Biol. 15 (2004) 521-527
22. Riley R.T., Wang E., Schroeder J.J., Smith E.R., Plattner R.D., Abbas H., Yoo H.S., and Merrill Jr. A.H. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Nat. Toxins 4 (1996) 3-15
23. Schumann J., Angermuller S., Bang R., Lohoff M., and Tiegs G. Acute hepatotoxicity of Pseudomonas aeruginosa exotoxin A in mice depends on T cells and TNF. J. Immunol. 161 (1998) 5745-5754
24. 1 toxicity in co-cultures: evidence for crosstalk between macrophages and non-parenchymatous liver epithelial cells involving proinflammatory cytokines. Toxicology 203 (2004) 239-251
25. Sharma R.P., Bhandari N., He Q., Riley R.T., and Voss K.A. Decreased fumonisin hepatotoxicity in mice with a targeted deletion of tumor necrosis factor receptor 1. Toxicology 159 (2001) 69-79
26. 1. J. Comp. Pathol. 117 (1997) 371-381
27. Sharma R.P., He Q., and Johnson V.J. Deletion of IFN-γ reduces fumonisin-induced hepatotoxicity in mice via alterations in inflammatory cytokines and apoptotic factors. J. Interferon Cytokine Res. 23 (2003) 13-23
28. Sharma R.P., He Q., and Riley R.T. Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine. Toxicology 216 (2005) 59-71
29. Shimamura M., Ohteki T., Launois P., Garcia A.M., and MacDonald H.R. Thymus-independent generation of NK1+ T cells in vitro from fetal liver precursors. J. Immunol. 158 (1997) 3682-3689
30. Smith E.R., and Merrill Jr. A.H. Differential roles of de novo sphingolipid biosynthesis and turnover in the "burst" of free sphingosine and sphinganine, and their 1-phosphates and N-acyl-derivatives, that occurs upon changing the medium of cells in culture. J. Biol. Chem. 270 (1995) 18749-18758
31. Streetz K., Fregien B., Plumpe J., Korber K., Kubicka S., Sass G., Bischoff S.C., Manns M.P., Tiegs G., and Trautwein C. Dissection of the intracellular pathways in hepatocytes suggests a role for Jun kinase and IFN regulatory factor-1 in con A-induced liver failure. J. Immunol. 167 (2001) 514-523
32. Sydenham E.W., Thiel P.G., Marasas W.F.O., Shephard G.S., Vanschalkwyk D.J., and Koch K.R. Natural occurrence of some Fusarium mycotoxins in corn from low and high esophageal cancer prevalence areas of the Transkei, Southern Africa. J. Agric. Food Chem. 38 (1990) 1900-1903
33. 1 alters the cytokine profile and decreases the vaccinal antibody titer in pigs. Toxicol. Sci. 84 (2005) 301-307
34. Tiegs G., Hentschel J., and Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90 (1992) 196-203
35. 1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice. J. Biochem. Mol. Toxicol. 12 (1998) 281-289
36. 1 in B6CF1 mice and Fischer 344 rats. Fundam. Appl. Toxicol. 24 (1995) 102-110
37. Wang W., Graeler M.H., and Goetzl E.J. Physiological sphingosine 1-phosphate requirement for optimal activity of mouse CD4+ regulatory T Cells. FASEB J. 18 (2004) 1043-1045
38. Wolf D., Hallmann R., Sass G., Sixt M., Kusters S., Fregien B., Trautwein C., and Tiegs G. TNF-α-induced expression of adhesion molecules in the liver is under the control of TNFR1- relevance for concanavalin A-induced hepatitis. J. Immunol. 166 (2001) 1300-1307
39. Zhang X., Ding L., and Sandford A.J. Selection of reference genes for gene expression studies in human neutrophils by real-time PCR. BMC Mol. Biol. 6 (2005) 4 10.1186/1471-2199-6-4